This statistic depicts the percentage of worldwide prescription drug revenue at risk due to patent expirations from 2010 to 2024. In 2012, around seven percent of the market was at risk due to patent expirations on pharmaceutical drug revenues.
Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Total worldwide prescription drug revenue growth - projection 2019-2024
- Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Saving of U.S. costs through generic cardiovascular pharmaceuticals 2004-2013
- Saving of U.S. costs through generic nervous system pharmaceuticals 2004-2013
- U.S. costs saved through generics by therapy 2004-2013
- Number of injection drugs that had shortages in Canada in 2013-2016, by company
- Distribution of injection drug shortages in Canada 2013-2016, by company
- Number of injection drug shortages in Canada 2013-2016, by company
- Forecast major categories of U.S. healthcare expenditures 2015-2020
- Annual price change in name brand drugs used mostly by older adults 2006-2017
- Price increase of brand drugs mostly used by US seniors by use and competition 2017
- Number of oral drugs that had shortages in Canada in 2013-2016, by company
- Price increase of geriatric drugs in the U.S. in 2017, by manufacturer
- Price disparities for top product Tamiflu - U.S. and international 2017
- Median number of days before limited drugs were discontinued Canada 2013-2016
- Total global melatonin supplements market size 2016 and 2021
- Pharmaceutical robots market revenue worldwide 2017-2027
- Global liquid biopsy market share by product type 2016 & 2025
- France: number of manufacturers of medical and dental instruments 2008-2016
- New Jersey/New York/Westchester Metro Area life sciences workforce 2013
Further related statistics
Evaluate. (June 4, 2019). Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024 [Graph]. In Statista. Retrieved December 10, 2019, from https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. "Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024." Chart. June 4, 2019. Statista. Accessed December 10, 2019. https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. (2019). Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024. Statista. Statista Inc.. Accessed: December 10, 2019. https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate. "Percentage of Global Prescription Drug Revenue at Risk from Patent Expiration from 2010 to 2024." Statista, Statista Inc., 4 Jun 2019, https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/
Evaluate, Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024 Statista, https://www.statista.com/statistics/309407/global-prescription-drug-revenue-percentage-at-risk-due-to-patent-expiration/ (last visited December 10, 2019)